Technology ❯ Biotechnology ❯ Drug Development
Phase 3 Trials Startups Organoid Applications Male Contraceptive Research Innovative Therapies Therapeutics Antivenom Research ADC Technology Antibody Treatments Antibody-Drug Conjugates Regulatory Approval
The Venrock-led financing positions NaPi2b-targeting TUB-040 for earlier-line studies ahead of an Oct. 19 data update.
